Rapid Sequence Intubation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Contingency Planning and Change Management
CHapteR 11 CONTINGENCY PLANNING AND CHANGE MANAGEMENT Introduction registration agency; for example: changes in Federal and State laws, budget fluctuations, relocation of Change in a voter registration and elections office is election office, staffing changes, agency reorganiza- inevitable, and effective management requires election tion, etc. Unlike contingencies, change management administrators to develop contingency and change focuses on events the office is already aware of and do management plans to respond to situations in a timely not rise unexpectedly. and effective manner. The goal of this chapter is to provide election officials general guidelines on how to identify, assess, and respond to events that may disrupt Identifying and assessing contingencies and election and voter registration services in their local change factors jurisdictions. The chapter addresses both contingency The first step in developing contingency and change planning and change management as they are inextri- management plans is to identify the contingencies cably linked to each other and may at times be devel- and change factors that can impact election and voter oped concurrently with each other. The goal of both registration practices and procedures in your particular these management plans is to prevent or minimize the community. This process is useful for several reasons. impact of change (expected or unexpected) on election First, it will help you define the goal of either your and voter registration processes, while preserving the contingency or change management plans. Second, it integrity of the electoral system. The recommendations will help you to objectively assess situations and their contained in this chapter should be vetted with Federal, potential impact. -
Distinct Muscarinic Acetylcholine Receptor Subtypes Contribute to Stability and Growth, but Not Compensatory Plasticity, of Neuromuscular Synapses
14942 • The Journal of Neuroscience, November 25, 2009 • 29(47):14942–14955 Development/Plasticity/Repair Distinct Muscarinic Acetylcholine Receptor Subtypes Contribute to Stability and Growth, But Not Compensatory Plasticity, of Neuromuscular Synapses Megan C. Wright,1 Srilatha Potluri,1 Xueyong Wang,2 Eva Dentcheva,1 Dinesh Gautam,3 Alan Tessler,1,4 Ju¨rgen Wess,3 Mark M. Rich,2 and Young-Jin Son1 1Department of Neurobiology and Anatomy, Drexel University College of Medicine, Philadelphia, Pennsylvania 19129, 2Department of Neuroscience, Cell Biology, and Physiology, Wright State University, Dayton, Ohio 45435, 3Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892, and 4Department of Neurology, Department of Veterans Affairs Hospital, Philadelphia, Pennsylvania 19104 Muscarinic acetylcholine receptors (mAChRs) modulate synaptic function, but whether they influence synaptic structure remains un- known. At neuromuscular junctions (NMJs), mAChRs have been implicated in compensatory sprouting of axon terminals in paralyzed or denervated muscles. Here we used pharmacological and genetic inhibition and localization studies of mAChR subtypes at mouse NMJs to demonstrate their roles in synaptic stability and growth but not in compensatory sprouting. M2 mAChRs were present solely in motor neurons,whereasM1 ,M3 ,andM5 mAChRswereassociatedwithSchwanncellsand/ormusclefibers.BlockadeofallfivemAChRsubtypes with atropine evoked pronounced effects, -
Infectious Waste Contingency Plan
Infectious Waste Contingency Plan Office of Environmental Health and Safety January 2012 Table of Contents I. Introduction……………………………………………………………………………..3 II. Facility Identification…………………………………………………………………..3 III. Emergency Contacts………………………………………………………………...3-4 IV. Scope and Responsibilities……………………………………………………………5 V. Infectious Waste Defined………………………………………….…………………...5 VI. Procedures for Infectious Waste Generators…………………………….………….5-6 VII. Infectious Waste Storage – EHS…………………………………………………......7 VIII. Infectious Waste Disposal – EHS…………………………………………………7-8 IX. Autoclaving – BGES…………………………………………………………………..8 X. Spill Containment and Cleanup Procedures…………………………………………8-10 XI. Training……………………………………………………………………………......10 XII. Records………………………………………………………………………………..11 XIII. Contingency for Disposal…………………………………………………………….11 Appendix A – Definitions……………………………………………………………...12-13 Appendix B – “Sharps” Management……………………………………………………...14 Appendix C – Infectious Waste Inventory Form……………………………………….15-16 Appendix D – Infectious Waste Storage Area Inspection Form………………………..17-18 Appendix E – Spill Log Form…………………………………………………………..19-20 2 I. Introduction In accordance with amendments set forth by the Ohio Environmental Protection Agency (OEPA) to the Ohio Administrative Code (OAC) Chapter 3745, Cleveland State University has declared itself a large quantity generator of infectious waste (generates greater than fifty or more pounds of infectious waste per month) and has developed this Infectious Waste Contingency Plan in order to comply with the -
Tracheal Intubation Following Traumatic Injury)
CLINICAL MANAGEMENT UPDATE The Journal of TRAUMA Injury, Infection, and Critical Care Guidelines for Emergency Tracheal Intubation Immediately after Traumatic Injury C. Michael Dunham, MD, Robert D. Barraco, MD, David E. Clark, MD, Brian J. Daley, MD, Frank E. Davis III, MD, Michael A. Gibbs, MD, Thomas Knuth, MD, Peter B. Letarte, MD, Fred A. Luchette, MD, Laurel Omert, MD, Leonard J. Weireter, MD, and Charles E. Wiles III, MD for the EAST Practice Management Guidelines Work Group J Trauma. 2003;55:162–179. REFERRALS TO THE EAST WEB SITE and impaired laryngeal reflexes are nonhypercarbic hypox- Because of the large size of the guidelines, specific emia and aspiration, respectively. Airway obstruction can sections have been deleted from this article, but are available occur with cervical spine injury, severe cognitive impairment on the Eastern Association for the Surgery of Trauma (EAST) (Glasgow Coma Scale [GCS] score Յ 8), severe neck injury, Web site (www.east.org/trauma practice guidelines/Emergency severe maxillofacial injury, or smoke inhalation. Hypoventi- Tracheal Intubation Following Traumatic Injury). lation can be found with airway obstruction, cardiac arrest, severe cognitive impairment, or cervical spinal cord injury. I. STATEMENT OF THE PROBLEM Aspiration is likely to occur with cardiac arrest, severe cog- ypoxia and obstruction of the airway are linked to nitive impairment, or severe maxillofacial injury. A major preventable and potentially preventable acute trauma clinical concern with thoracic injury is the development of Hdeaths.1–4 There is substantial documentation that hyp- nonhypercarbic hypoxemia. Lung injury and nonhypercarbic oxia is common in severe brain injury and worsens neuro- hypoxemia are also potential sequelae of aspiration. -
ISPUB - Dilemma in Rapid Sequence Intubation: Succinylcholi
ISPUB - Dilemma In Rapid Sequence Intubation: Succinylcholi... http://www.ispub.com/journal/the_internet_journal_of_emerge... The Internet Journal of Emergency and Intensive Care Medicine 2003 : Volume 7 Number 1 Dilemma In Rapid Sequence Intubation: Succinylcholine Vs. Rocuronium Ozgur Karcioglu MD Emergency Physician Dept. of Emergency Medicine Dokuz Eylul Univ. School of Medicine Izmir Turkey Citation: O. Karcioglu : Dilemma In Rapid Sequence Intubation: Succinylcholine Vs. Rocuronium . The Internet Journal of Emergency and Intensive Care Medicine. 2003 Volume 7 Number 1 Keywords: Rapid sequence intubation | rapid sequence induction | neuromuscular blockade | muscle paralysis | succinylcholine | rocuronium Abstract Succinylcholine is the single ultra-short acting depolarizing neuromuscular blocking agent (NMBA) used in the rapid sequence intubation protocol with 1 of 14 9/8/10 11:29 PM ISPUB - Dilemma In Rapid Sequence Intubation: Succinylcholi... http://www.ispub.com/journal/the_internet_journal_of_emerge... its rapid onset of effect, complete reliability, short duration of action. Rocuronium is diverse from other non-depolarizing NMBA being the first one with a short onset time and devoid of untoward effects. Despite its widespread use, succinylcholine has several potential hazards including an increase in potassium levels, bradycardia for children and prolonged apnea for those with pseudocholinesterase deficiency. Rocuronium is indicated in subjects with disease states such as known or suspected hyperkalemia, crush injury, non-acute burns, increased intracranial or intraocular pressure and neuromuscular disease. Although succinylcholine has many side effects, it remains to be the first-choice NMBA for the majority of attempts for rapid sequence intubation. Rocuronium may be a suitable alternative to succinylcholine with its short onset time. The objective of this article is to update data from studies comparing the use of succinylcholine and rocuronium in rapid sequence intubation protocol in adults. -
Muscarinic Acetylcholine Type 1 Receptor Activity Constrains Neurite Outgrowth by Inhibiting Microtubule Polymerization and Mito
fnins-12-00402 June 26, 2018 Time: 12:46 # 1 ORIGINAL RESEARCH published: 26 June 2018 doi: 10.3389/fnins.2018.00402 Muscarinic Acetylcholine Type 1 Receptor Activity Constrains Neurite Outgrowth by Inhibiting Microtubule Polymerization and Mitochondrial Trafficking in Adult Sensory Neurons Mohammad G. Sabbir1*, Nigel A. Calcutt2 and Paul Fernyhough1,3 1 Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, Winnipeg, MB, Canada, 2 Department of Pathology, University of California, San Diego, San Diego, CA, United States, 3 Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada The muscarinic acetylcholine type 1 receptor (M1R) is a metabotropic G protein-coupled Edited by: receptor. Knockout of M1R or exposure to selective or specific receptor antagonists Roberto Di Maio, elevates neurite outgrowth in adult sensory neurons and is therapeutic in diverse University of Pittsburgh, United States models of peripheral neuropathy. We tested the hypothesis that endogenous M1R Reviewed by: activation constrained neurite outgrowth via a negative impact on the cytoskeleton Roland Brandt, University of Osnabrück, Germany and subsequent mitochondrial trafficking. We overexpressed M1R in primary cultures Rick Dobrowsky, of adult rat sensory neurons and cell lines and studied the physiological and The University of Kansas, United States molecular consequences related to regulation of cytoskeletal/mitochondrial dynamics *Correspondence: and neurite outgrowth. In adult primary neurons, overexpression of M1R caused Mohammad G. Sabbir disruption of the tubulin, but not actin, cytoskeleton and significantly reduced neurite [email protected] outgrowth. Over-expression of a M1R-DREADD mutant comparatively increased neurite Specialty section: outgrowth suggesting that acetylcholine released from cultured neurons interacts This article was submitted to with M1R to suppress neurite outgrowth. -
WO 2017/177262 Al 19 October 2017 (19.10.2017) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/177262 Al 19 October 2017 (19.10.2017) P O P C T (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 31/198 (2006.01) A61P 27/02 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, A61K 31/375 (2006.01) A61P 27/10 (2006.01) DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, (21) International Application Number: KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, PCT/AU20 17/0503 10 MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, (22) International Filing Date: NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, 10 April 2017 (10.04.2017) RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, (25) Filing Language: English ZA, ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 2016901339 11 April 2016 ( 11.04.2016) AU GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: UNIVERSITY OF CANBERRA [AU/AU]; TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, University Drive, Bruce, Australian Capital Territory 2617 DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, (AU). -
Contingency Plan and Emergency Procedures Checklist Page 1
Site: _____________________ EPA #: _______________ Date: __________ Contingency Plan and Emergency Procedures Checklist Note: this checklist is applicable to LQG's and to HSM handlers (except where indicated) who accumulate >6,000 kg (~13,228 lbs.) INSPECTION ITEM CITATION COMMENTS General Requirements: Have copies been distributed to all local police and R315-262-17(a)(6) (LQG) fire departments, hospitals, and State and local R315-262-262(a) (LQG) emergency response teams that may be called upon R315-261-420(c)(2) (HSM) for assistance? Content of the Contingency Plan: 1. Does the contingency plan describe the actions facility personnel will take to minimize the R315-262-261(a) (LQG) hazard to human health or the environment when R315-261-420(b)(1) (HSM) responding to fires, explosions, or any unplanned sudden or non-sudden release of hazardous waste? 2. Does the contingency plan describe arrangements agreed to by local police and fire R315-262-261(c) (LQG) departments, hospitals, contractors, and State and R315-261-420(b)(3) (HSM) local emergency response teams? 3. Does the contingency plan list the names, addresses, and phone numbers (office and R315-262-261(d) (LQG) home) of primary and all other persons R315-261-420(b)(4) (HSM) qualified to act as emergency coordinator? 4. Does the contingency plan include a list of all emergency equipment at the facility? The list R315-262-261(e) (LQG) must be kept up-to-date, and include the location R315-261-420(b)(5) (HSM) and a physical description of each item on the list, and a brief outline of the equipment's capability. -
Airway Management for COVID 19
Airway Management in Critically Ill COVID-19 Patients KATHERINE HELLER, MD ASSISTANT PROFESSOR UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE DEPARTMENT OF ANESTHESIOLOGY MEDICAL DIRECTOR: UWMC SICU Disclosures (none) Outline Staff safety PPE Patient factors/ timing Adjuncts for oxygenation Intubation procedure Preparation Equipment/technique Unusual situations Difficult airways Tracheostomy Emergencies Opening Questions Please navigate to pollev.com/katherinehel603 Priorities Priority #1: Staff Safety Considerations for Staff Procedural planning Appropriate PPE takes time Avoid emergencies when able Consider rounding (remotely?) on known COVID patients PPE Any airway management is an Aerosol Generating Procedure (AGP) Need respirator level protections airborne + contact/droplet N95 vs PAPR N95 PAPR Pro Pro Easy to don Comfortable Fast Protect face, neck, head Allow use of stethoscope Reusable More readily available Con Con Allows contamination of Require power source face and neck Need assistance to don Less comfortable and doff May not fit everyone Noisy Fit can change Infection Control Choose what work for you and your institution More important to have clear protocols and expectations Minimize in room staff Have equipment easily available Filter in line on circuit Infection control Barrier Devices Not recommended Additional encumbrance to intubation without proven benefit Not a replacement for PPE May actually increase risk [11] Failed airway Breach of PPE FDA revoked EUA for barrier devices in -
Rapid Sequence Induction Will Ross and Louise Ellard
Update in Anaesthesia Rapid sequence induction Will Ross and Louise Ellard Correspondence: [email protected] Originally published as Anaesthesia Tutorial of the Week 331, 24 May 2016, edited by Dr Luke Baitch Table 1. Common modifications of RSI technique in INTRODUCTION current practice Rapid sequence induction (RSI) is a method of achiev- Omitting the placement of an oesophageal tube articlesClinical overview ing rapid control of the airway whilst minimising Supine or ramped positioning the risk of regurgitation and aspiration of gastric Titrating the dose of induction agent to loss of contents. Intravenous induction of anaesthesia, with consciousness the application of cricoid pressure, is swiftly followed Summary by the placement of an endotracheal tube (ETT). Use of propofol, ketamine, midazolam or etomidate to Rapid sequence induction induce anaesthesia (RSI) is intended to reduce Performance of an RSI is a high priority in many the risk of aspiration by emergency situations when the airway is at risk, and Use of high-dose rocuronium as a neuromuscular blocking agent minimising the duration is usually an essential component of anaesthesia for of an unprotected airway. Omitting cricoid pressure emergency surgical interventions. RSI is required only Preparation and planning in patients with preserved airway reflexes. In arrested – including technique, or completely obtunded patients, an endotracheal tube medications, team member can usually be placed without the use of medications. CRICOID PRESSURE roles and contingencies -
Muscarinic Toxin 7 Signals Via Ca2+/Calmodulin-Dependent Protein Kinase Kinase Β to Augment Mitochondrial Function and Prevent Neurodegeneration
Molecular Neurobiology (2020) 57:2521–2538 https://doi.org/10.1007/s12035-020-01900-x Muscarinic Toxin 7 Signals Via Ca2+/Calmodulin-Dependent Protein Kinase Kinase β to Augment Mitochondrial Function and Prevent Neurodegeneration Ali Saleh1 & Mohammad Golam Sabbir1 & Mohamad-Reza Aghanoori1,2 & Darrell R. Smith1 & Subir K. Roy Chowdhury1 & Lori Tessler1 & Jennifer Brown1 & Eva Gedarevich3 & Markos Z. Kassahun3 & Katie Frizzi3 & Nigel A. Calcutt 3 & Paul Fernyhough1,2 Received: 9 January 2020 /Accepted: 9 March 2020 /Published online: 20 March 2020 # The Author(s) 2020 Abstract Mitochondrial dysfunction is implicated in a variety of neurodegenerative diseases of the nervous system. Peroxisome proliferator–activated receptor-γ coactivator-1α (PGC-1α) is a regulator of mitochondrial function in multiple cell types. In sensory neurons, AMP-activated protein kinase (AMPK) augments PGC-1α activity and this pathway is depressed in diabetes leading to mitochondrial dysfunction and neurodegeneration. Antimuscarinic drugs targeting the muscarinic acetylcholine type 1 receptor (M1R) prevent/reverse neurodegeneration by inducing nerve regeneration in rodent models of diabetes and chemotherapy-induced peripheral neuropathy (CIPN). Ca2+/calmodulin-dependent protein kinase kinase β (CaMKKβ)isan upstream regulator of AMPK activity. We hypothesized that antimuscarinic drugs modulate CaMKKβ to enhance activity of AMPK, and PGC-1α, increase mitochondrial function and thus protect from neurodegeneration. We used the specific M1R antagonist muscarinic toxin 7 (MT7) to manipulate muscarinic signaling in the dorsal root ganglia (DRG) neurons of normal rats or rats with streptozotocin-induced diabetes. DRG neurons treated with MT7 (100 nM) or a selective muscarinic antagonist, pirenzepine (1 μM), for 24 h showed increased neurite outgrowth that was blocked by the CaMKK inhibitor STO-609 (1 μM) or short hairpin RNA to CaMKKβ. -
Case Report Carbamazepine Toxicity Following Oxybutynin And
Spinal Cord (2005) 43, 252–255 & 2005 International Spinal Cord Society All rights reserved 1362-4393/05 $30.00 www.nature.com/sc Case Report Carbamazepine toxicity following Oxybutynin and Dantrolene administration: a case report T Vander*,1, H Odi1, V Bluvstein1, J Ronen1,2 and A Catz1,2 1Department of Spinal Rehabilitation, Loewenstein Rehabilitation Hospital, Raanana, Israel; 2Tel-Aviv University, Tel-Aviv, Israel Objective: To report a case of Carbamazepine toxicity following the administration of Oxybutynin and Dantrolene. Study design: A case report. Setting: The Spinal Rehabilitation Department, Loewenstein Hospital, Raanana, Israel. Methods: A patient with C6D tetraplegia who sustained intoxication because of drug interaction is presented. She had been treated by Carbamazepine 1000 mg/day for neuropathic pain for 2 years without clinical or laboratory signs of toxicity. After administration of Oxybutynin concomitantly with an increase in the dose of Dantrolene, she presented the clinical symptoms and laboratory finding of Carbamazepine intoxication. Trying to adjust the treatment to the patient’s requirements, Carbamazepine together with Oxybutynin and Dantrolene was readministrated in lower doses. Results: The combination of these drugs, even small doses, caused toxicity. Adding Dantrolene and Oxybutynin elevated the blood level of Carbamazepine, possibly by inhibition of cytochrome P450. Conclusion: A possible pharmacokinetic interaction between Dantrolene and Oxybutynin should be borne in mind when considering Carbamazepine medication for a patient with a spinal cord lesion. Spinal Cord (2005) 43, 252–255. doi:10.1038/sj.sc.3101689; Published online 1 February 2005 Keywords: Carbamazepine; Oxybutynin; Dantrolene; drug interaction; cytochrome P450 Introduction Both Oxybutynin chloride and Dantrolene sodium are be required when patients have concomitant post- widely used in patients with spinal cord lesion (SCL).